体外反搏辅助治疗糖尿病并早期肾病90例

Enhanced External Counterpulsation in Treating 90 Cases of Diabetes with Early Nephropathy

目的:对体外反搏辅助治疗糖尿病并早期肾病的临床价值进行探讨。方法:将180例糖尿病肾病患者分为两组,对90例患者进行常规治疗,作为对照组;对于其余的90例患者在常规治疗的基础上用体外反搏辅助治疗,作为治疗组。结果:进行体外反搏治疗之后,治疗组中的糖尿病肾病Ⅲ、Ⅳ期患者24 h尿白蛋白、尿及血β2-微球蛋白比对照组明显少(P<0.01、P<0.05)。与治疗前相比明显下降(P<0.01、P<0.05)。治疗组糖尿病肾病Ⅴ期患者在治疗前和治疗后与对照组进行同期比较差异无统计学意义(P>0.05)。结论:体外反搏辅助治疗可以使得早期的糖尿病肾病患者的24 h尿白蛋白、尿及血β2-微球蛋白的总体水平降低,并在一定的程度上保护了患者的肾脏功能。

Objective：To research enhanced external counterpulsation in treating 180 cases of diabetes with early nephropathy.Method：180 cases of diabetic nephropathy patients were divided into two groups,receiving conventional treatment,90 patients as control group.For the rest of the 90 patients in the conventional treatment on the basis of enhanced exteanal counterpulsation therapy,were selected as treatment group.Result：After the treatment of enhanced external counterpulsation in the treatment group of patients with diabetic nephropathy Ⅲ,Ⅳperiod within 24 h urinary albumin and urine and blood beta 2-microglobulin significantly decreased than the control group（P＆lt;0.01,P＆lt;0.05）.Compared with before treatment significantly decreased（P＆lt;0.01,P＆lt;0.05）.The differences V stage of diabetic nephropathy in treatment group patients before treatment and after treatment over the same period compared with control group,was no statistical significance（P＆gt;0.05）.Conclusion：Enhanced external counterpulsation can be reduce overall level of 24 h urinary albumin and urine and blood beta 2-microglobulin of early diabetic nephropathy patients,and to a certain extent can protect the patient’s kidney function.